Biography:Celine Marmion
Celine J. Marmion | |
|---|---|
| Alma mater | University of Surrey (PhD) Kingston University (PGCE) |
| Scientific career | |
| Institutions | St Mary's University, Twickenham Royal College of Surgeons in Ireland |
Celine J. Marmion is a Professor of Chemistry at the Royal College of Surgeons in Ireland and President of the Institute of Chemistry of Ireland. She is a Fellow of the Royal Society of Chemistry and the Institute of Chemistry of Ireland. Marmion is involved with the design of new chemotherapeutic drugs.
Early life and education
Marmion earned her doctoral degree at the University of Surrey in 1994.[1] Her PhD research involved investigations into vanadium complexes and nitrogen fixation. In 1994 Marmion was appointed as a lecturer at St Mary's University, Twickenham, where she worked until 1995.[2] She returned to study in 1995, and earned a Postgraduate Certificate in Education (PGCE) at Kingston University.[3]
Research and career
In 1997 Marmion joined Royal College of Surgeons in Ireland as a lecturer in the Department of Chemistry.[2] She was promoted to Associate Professor in 2013 and Professor in 2018. Her research considers the design of metal-based chemotherapeutic drugs. In particular, this has included the design of targeted PtIV prodrugs.[4][5] Immunodeficient cancer patients are at risk of developing infections, which occasionally require antimicrobial prophylaxis. To better serve these patients Marmion developed a family of metallo-antibiotics, based on a Cu-N,N-framework, which can bind to DNA, has DNA oxidant properties and has antiproliferative and antimicrobial properties.[6] Her research has been supported by the Science Foundation Ireland (SFI) to create a prodrug strategy for multi-modal chemotherapeutics.[7]
Awards and honours
Her awards and honours include:
- 2009 Royal College of Surgeons in Ireland President's Teaching Award 'for excellence in teaching'[8]
- 2010 Vice-Dean of the Royal College of Surgeons in Ireland Faculty of Medicine & Health Sciences[8]
- 2013 President of the Irish Biological Inorganic Chemistry Society
- 2013 Elected Fellow of the Royal Society of Chemistry[4]
- 2015 Elected Fellow of the Institute of Chemistry of Ireland[3]
- 2015 Royal College of Surgeons in Ireland President's Teaching Award 'for excellence in teaching'[8]
- 2016 Royal College of Surgeons in Ireland Dean's Academic Award for 'Endeavour, Innovation, Collaboration and Service'[9]
- 2017 Irish Network of Healthcare Educators Education Research Grant[10]
- 2017 Vice President of the Institute of Chemistry of Ireland[11]
- 2019 President of the Institute of Chemistry of Ireland[12]
Selected publications
Her publications include:
- Marmion, Celine (2019). Metal-based Anticancer Agents. Royal Society of Chemistry. ISBN 9781788014069.
- Marmion, Celine J. (2004). "Hydroxamic Acids− An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands". European Journal of Inorganic Chemistry 2004 (15): 3003–3016. doi:10.1002/ejic.200400221.
- Marmion, Celine J. (2000). "Hydroxamic acids are nitric oxide donors. Facile formation of ruthenium(II)-nitrosyls and NO-mediated activation of guanylate cyclase by hydroxamic acids". Chemical Communications (13): 1153–1154. doi:10.1039/B001631O.
References
- ↑ Dublin, T. U.. "TU Dublin News" (in en). https://www.dit.ie/newsandevents/news/archive2017/news/title146043en.html.
- ↑ 2.0 2.1 "Dr Celine Marmion – Biography". https://www.ucd.ie/cscb/main_pages/research/researchers/marmion_celine/index.html.
- ↑ 3.0 3.1 "Profile" (in en). https://www.rcsi.com/people/profile/rcostello.
- ↑ 4.0 4.1 Kenny, Reece G.; Chuah, Su Wen; Crawford, Alanna; Marmion, Celine J. (2017). "Platinum(IV) Prodrugs – A Step Closer to Ehrlich's Vision?" (in en). European Journal of Inorganic Chemistry 2017 (12): 1596–1612. doi:10.1002/ejic.201601278. ISSN 1099-0682.
- ↑ Kenny, Reece G.; Marmion, Celine J. (2019-01-23). "Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?". Chemical Reviews 119 (2): 1058–1137. doi:10.1021/acs.chemrev.8b00271. ISSN 0009-2665. PMID 30640441.
- ↑ Ude, Ziga; Kavanagh, Kevin; Twamley, Brendan; Pour, Milan; Gathergood, Nicholas; Kellett, Andrew; Marmion, Celine J. (2019-06-18). "A new class of prophylactic metallo-antibiotic possessing potent anti-cancer and anti-microbial properties" (in en). Dalton Transactions 48 (24): 8578–8593. doi:10.1039/C9DT00250B. ISSN 1477-9234. PMID 30946409. https://mural.maynoothuniversity.ie/14994/1/KK_a%20new%20class.pdf.
- ↑ Harrington, James (2018-10-30). "€3.5m investment in research commercialisation unveiled" (in en-US). http://www.engineersjournal.ie/2018/10/30/e3-5m-investment-research-commercialisation-unveiled/.
- ↑ 8.0 8.1 8.2 "Speakers – Celebrating Research – Past, Present, Future – Royal College Surgeons in Ireland". https://rcsi.ie/spgsspeakers.
- ↑ "RCSI Dean's Academic Award". https://www.rcsi.ie/index.jsp?n=110&p=100&a=9083.
- ↑ inmedlogin. "Past Recipients" (in en-US). https://www.inhed.ie/past-recipients/.
- ↑ "Annual General Meeting 2017 | Photo gallery | Institute of Chemistry of Ireland". http://www.chemistryireland.org/html/agm2017-photos.html.
- ↑ "Meet…" (in en-US). 2019-11-06. https://www.euchems.eu/newsletters/chemistry-in-europe-2019-4/meet/.
 |  |
